Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$177,714,563
+$67,089,939 QoQ
Shares Held
4,373,974
-1.9% QoQ
Ownership
4.03%
of shares outstanding
% of Portfolio
2.87%
of 13F equity value
Holder Rank
#9
of 223 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Derivatives in EWTX
reported options exposure · as of Mar 31, 2025CallValue
$11,000,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. EWTX ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in EWTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,714,563 | 4,373,974 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $110,624,624 | 4,457,974 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $61,569,400 | 3,795,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,829,731 | 4,639,949 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $144,041,216 | 6,547,328 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $11,000,000 | 500,000 | Call | Sole | 2025-08-06 | |
| 2025-02-13 | $134,379,951 | 5,164,487 | Shares | Sole | 2025-02-21 | |
| 2024-12-31 | $71,703,837 | 2,685,537 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $62,195,546 | 2,330,294 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,434,070 | 1,856,417 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $42,310,343 | 2,319,646 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,077,771 | 555,555 | Shares | Sole | 2024-02-26 | |
| No filing history on record for this holder in this stock. | ||||||